Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

19 structures for P47871

Entry ID Method Resolution Chain Position Source
2A83 X-ray 140 A C 412-420 PDB
3CZF X-ray 120 A C 412-420 PDB
4ERS X-ray 264 A A 28-123 PDB
4L6R X-ray 330 A A 123-432 PDB
4LF3 X-ray 274 A C/F 29-123 PDB
5EE7 X-ray 250 A PDB
5XEZ X-ray 300 A A/B 27-432 PDB
6LMK EM 370 A R 27-432 PDB
6LML EM 390 A R 27-432 PDB
6WHC EM 340 A R 1-477 PDB
6WPW EM 310 A R 27-477 PDB
7V35 EM 340 A R 27-432 PDB
8FU6 EM 290 A R 27-477 PDB
8JIQ EM 340 A R 27-431 PDB
8JIT EM 291 A R 27-431 PDB
8JIU EM 276 A R 27-431 PDB
8JRU EM 350 A R 27-432 PDB
8JRV EM 330 A R 27-432 PDB
AF-P47871-F1 Predicted AlphaFoldDB

402 variants for P47871

Variant ID(s) Position Change Description Diseaes Association Provenance
CA126242
VAR_003581
RCV000950476
rs1801483
RCV000017542
40 G>S Type 2 diabetes mellitus no effect on glucagon-elicited cAMP production [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA401492115
rs1219737977
VAR_085613
63 D>N MVAH [UniProt] Yes ClinGen
TOPMed
gnomAD
UniProt
VAR_069815 86 P>S MVAH; abolishes glucagon binding [UniProt] Yes UniProt
CA8842106
VAR_085615
rs371217388
225 R>H MVAH; when associated in cis with M-368; decreased glucagon binding and decreased glucagon-elicited cAMP production; decreased localization to the cell membrane [UniProt] Yes ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
UniProt
RCV000727657
RCV001374862
rs1202703638
320 F>missing GCGR-related hyperglucagonemia [ClinVar] Yes ClinVar
dbSNP
VAR_085616 320 F>del MVAH; loss of glucagon-elicited cAMP production; no effect on localization to the cell membrane [UniProt] Yes UniProt
VAR_085618
CA8842187
rs771824180
368 V>M Variant assessed as Somatic; 0.0 impact. MVAH; when associated in cis with H-225; decreased glucagon binding and decreased glucagon-elicited cAMP production; no effect on localization to the cell membrane [NCI-TCGA, UniProt] Yes ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
UniProt
CA401488473
rs1374465504
2 P>S No ClinGen
gnomAD
rs1050897506
CA295097300
3 P>L No ClinGen
TOPMed
gnomAD
CA8841971
rs746335439
3 P>S No ClinGen
ExAC
gnomAD
CA401488490
rs746335439
3 P>T No ClinGen
ExAC
gnomAD
rs1271734930
CA401488573
5 Q>P No ClinGen
TOPMed
gnomAD
CA401488590
rs1227577161
6 P>T No ClinGen
TOPMed
CA8841972
rs770387110
8 R>* No ClinGen
ExAC
gnomAD
rs773994205
CA8841973
8 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA401488754
rs1233390237
9 P>L No ClinGen
TOPMed
gnomAD
rs1280999107
CA401488725
9 P>S No ClinGen
TOPMed
CA401488858
rs1568249921
13 L>V No ClinGen
Ensembl
rs953530197
CA295097339
17 L>P No ClinGen
TOPMed
gnomAD
rs1335228562
CA401489048
18 A>D No ClinGen
TOPMed
gnomAD
rs1054447666
CA295097347
19 C>W No ClinGen
TOPMed
gnomAD
TCGA novel 20 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs746310016
CA8841998
22 Q>* No ClinGen
ExAC
gnomAD
rs1323911527
CA401490904
24 P>H No ClinGen
TOPMed
gnomAD
CA8841999
rs770131289
26 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA295098035
rs1020960200
27 Q>E No ClinGen
TOPMed
rs747611271
CA8842001
29 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs1480166504
CA401491060
30 D>G No ClinGen
gnomAD
CA401491049
rs1263930997
30 D>H No ClinGen
gnomAD
CA401491078
rs1598236171
31 F>L No ClinGen
Ensembl
CA401491125
rs1568251231
33 F>L No ClinGen
Ensembl
CA401491173
rs1407252418
36 W>R No ClinGen
TOPMed
CA401491273
rs1158418305
40 G>A No ClinGen
TOPMed
gnomAD
CA8842003
rs760232106
41 D>E No ClinGen
ExAC
gnomAD
rs984272223
CA295098070
45 H>Y No ClinGen
TOPMed
gnomAD
rs1364365831
CA401491468
48 S>N No ClinGen
gnomAD
rs1017028958
CA295098091
51 P>L No ClinGen
Ensembl
rs1331669976
CA401491553
52 P>S No ClinGen
TOPMed
gnomAD
CA401491548
rs1331669976
52 P>T No ClinGen
TOPMed
gnomAD
CA401491589
rs373371585
54 T>K No ClinGen
ExAC
TOPMed
gnomAD
CA8842004
rs373371585
54 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA8842019
rs561472081
60 R>T No ClinGen
1000Genomes
ExAC
gnomAD
rs1381720436
CA401492096
62 F>L No ClinGen
gnomAD
rs1293577571
CA401492108
62 F>Y No ClinGen
gnomAD
rs1283204989
CA401492128
63 D>A No ClinGen
gnomAD
rs918559897
CA295099122
68 W>* No ClinGen
Ensembl
CA401492315
rs1321774988
68 W>* No ClinGen
gnomAD
CA295099142
rs576194179
69 P>L No ClinGen
TOPMed
gnomAD
TCGA novel 71 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs780665566
CA8842021
71 T>P No ClinGen
ExAC
gnomAD
rs868431560
CA401492400
73 A>P No ClinGen
TOPMed
gnomAD
CA295099144
rs868431560
73 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA8842022
rs189736697
VAR_085614
76 T>M no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
UniProt
CA295099182
rs899064710
79 I>M No ClinGen
TOPMed
gnomAD
CA295099158
rs1038824634
79 I>V No ClinGen
TOPMed
gnomAD
rs1453383640
CA401492668
82 P>L No ClinGen
gnomAD
CA401492654
rs1378394827
82 P>S No ClinGen
TOPMed
gnomAD
rs2229153
CA295099202
84 Y>D No ClinGen
Ensembl
rs1598237321
CA401492736
84 Y>S No ClinGen
Ensembl
CA8842024
rs755602452
88 H>N No ClinGen
ExAC
TOPMed
gnomAD
rs1164994335
CA401493100
93 H>P No ClinGen
TOPMed
CA401493105
rs1222169977
93 H>Q No ClinGen
gnomAD
rs552010052
CA8842039
94 R>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA295099352
rs1022912945
94 R>H No ClinGen
TOPMed
gnomAD
rs756454904
CA401493153
96 V>A No ClinGen
ExAC
gnomAD
CA8842041
rs756454904
96 V>E No ClinGen
ExAC
gnomAD
CA401493139
rs1240225006
96 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA401493183
rs1253073377
98 K>R No ClinGen
gnomAD
rs1193513499
CA401493200
99 R>S No ClinGen
gnomAD
CA295099386
rs1039904981
99 R>T No ClinGen
TOPMed
CA295099404
rs373865736
101 G>R No ClinGen
ESP
TOPMed
gnomAD
TCGA novel 101 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 102 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA401493242
rs779580966
103 D>H No ClinGen
ExAC
TOPMed
gnomAD
rs779580966
CA8842045
103 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA401493259
rs1377157654
104 G>S No ClinGen
TOPMed
gnomAD
rs1451404133
CA401493268
105 Q>* No ClinGen
gnomAD
CA295099466
rs958325026
107 V>L No ClinGen
TOPMed
CA401493310
rs1312508282
108 R>H No ClinGen
TOPMed
gnomAD
rs531183455
CA295099480
109 G>R No ClinGen
1000Genomes
rs1228449257
CA401493331
110 P>H No ClinGen
gnomAD
rs1043477675
CA295099481
110 P>S No ClinGen
TOPMed
gnomAD
CA295099495
rs28522411
111 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA8842046
COSM3821013
rs28522411
111 R>Q breast [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs1272192802
CA401493341
111 R>W No ClinGen
TOPMed
gnomAD
rs1258411324
CA401493356
112 G>E No ClinGen
TOPMed
gnomAD
CA401493378
rs1372556587
113 Q>R No ClinGen
gnomAD
VAR_014837
CA8842047
rs5385
114 P>A No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA295099498
rs5385
114 P>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA401493413
rs1235960477
115 W>* No ClinGen
TOPMed
gnomAD
rs1473810541
CA401493421
115 W>* No ClinGen
gnomAD
CA401493418
rs1235960477
115 W>L No ClinGen
TOPMed
gnomAD
CA401493415
rs1235960477
115 W>S No ClinGen
TOPMed
gnomAD
CA401493433
rs1364717865
116 R>C No ClinGen
TOPMed
CA295099501
rs567794794
116 R>H No ClinGen
1000Genomes
TOPMed
gnomAD
rs1271662476
CA401493485
119 S>T No ClinGen
TOPMed
gnomAD
rs1305456353
CA401493514
120 Q>R No ClinGen
gnomAD
CA401493540
rs1431639891
121 C>Y No ClinGen
TOPMed
rs780610679
CA8842048
123 M>I No ClinGen
ExAC
gnomAD
CA295099506
rs535086486
123 M>V No ClinGen
1000Genomes
TOPMed
rs745508664
CA8842049
124 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA8842050
rs529078630
125 G>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA295099536
rs889041091
126 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA8842052
rs181081681
128 I>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1008826316
CA295099541
130 V>F No ClinGen
TOPMed
gnomAD
CA401493793
rs536878804
132 K>N No ClinGen
1000Genomes
TOPMed
gnomAD
TCGA novel 133 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1229061446
CA401493797
133 E>K No ClinGen
TOPMed
rs1229061446
CA401493798
133 E>Q No ClinGen
TOPMed
rs914778371
CA295099695
134 V>G No ClinGen
Ensembl
CA295099693
rs555106408
134 V>M No ClinGen
1000Genomes
CA295099697
rs573421080
135 A>T No ClinGen
1000Genomes
TOPMed
gnomAD
rs947568418
CA295099713
137 M>I No ClinGen
TOPMed
gnomAD
CA401493905
rs1490347408
139 S>N No ClinGen
gnomAD
rs754197868
CA8842060
140 S>N No ClinGen
ExAC
gnomAD
rs1478580187
CA401493963
141 F>L No ClinGen
gnomAD
CA295099722
rs868372915
141 F>L No ClinGen
Ensembl
CA401494014
rs1157583633
143 V>A No ClinGen
gnomAD
rs992477377
CA295099745
144 M>I No ClinGen
TOPMed
CA401494068
rs1269119839
145 Y>N No ClinGen
TOPMed
gnomAD
CA401494143
rs1420954588
146 T>R No ClinGen
gnomAD
rs540678391
CA295099760
150 S>N No ClinGen
1000Genomes
CA401494283
rs1384946984
151 L>M No ClinGen
gnomAD
CA401494286
rs1384946984
151 L>V No ClinGen
gnomAD
rs755419233
CA8842061
155 A>T No ClinGen
ExAC
gnomAD
rs1308768319
CA401494439
155 A>V No ClinGen
gnomAD
rs902279512
CA295099796
157 L>H No ClinGen
TOPMed
rs902279512
CA295099797
157 L>P No ClinGen
TOPMed
rs758874938
CA8842064
159 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1355739079
CA401494634
161 A>T No ClinGen
gnomAD
rs896113818
CA295099831
164 G>R No ClinGen
TOPMed
rs1044952705
CA295099840
165 G>A No ClinGen
TOPMed
rs1044952705
CA295099835
165 G>D No ClinGen
TOPMed
CA401494782
rs1222914520
165 G>S No ClinGen
gnomAD
TCGA novel 166 L>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1241628118
CA401494819
166 L>R No ClinGen
gnomAD
rs1385535030
CA401494839
167 S>N No ClinGen
TOPMed
CA295099971
CA401494959
rs969354907
167 S>R No ClinGen
TOPMed
gnomAD
rs1315009031
CA401495002
170 H>Y No ClinGen
gnomAD
CA401495073
rs1276893614
172 T>I No ClinGen
TOPMed
gnomAD
rs977633447
CA295099991
172 T>P No ClinGen
Ensembl
CA401495081
rs867133127
173 R>C No ClinGen
gnomAD
rs867051527
CA295099998
173 R>H No ClinGen
TOPMed
gnomAD
rs867051527
CA401495092
173 R>L No ClinGen
TOPMed
gnomAD
rs867133127
CA295099993
173 R>S No ClinGen
gnomAD
CA401495098
rs1255016906
174 N>D No ClinGen
gnomAD
rs1482107974
CA401495121
175 A>T No ClinGen
gnomAD
rs1201839849
CA401495133
175 A>V No ClinGen
gnomAD
rs1487695265
CA401495200
178 A>T No ClinGen
TOPMed
gnomAD
rs571642081
CA295100024
178 A>V No ClinGen
1000Genomes
TOPMed
gnomAD
rs756243536
CA401495243
179 N>D No ClinGen
gnomAD
CA295100060
rs1027790160
179 N>T No ClinGen
TOPMed
gnomAD
rs756243536
CA295100047
179 N>Y No ClinGen
gnomAD
rs550681728
CA295100066
182 A>V No ClinGen
1000Genomes
TOPMed
gnomAD
CA295100081
rs951819372
183 S>F No ClinGen
TOPMed
CA401495388
rs1225544346
185 V>M No ClinGen
TOPMed
CA401495439
rs1399499869
187 K>E No ClinGen
gnomAD
rs1296860048
CA401495498
189 S>I No ClinGen
gnomAD
CA295100108
rs1044985218
191 V>M No ClinGen
TOPMed
gnomAD
CA401495588
rs1457619135
193 V>D No ClinGen
TOPMed
rs1481186146
CA401495614
194 I>T No ClinGen
TOPMed
rs985911098
CA295100144
194 I>V No ClinGen
TOPMed
rs1310818080
CA401495756
200 T>A No ClinGen
gnomAD
rs1234915081
CA401495765
200 T>I No ClinGen
gnomAD
rs1310818080
CA401495760
200 T>S No ClinGen
gnomAD
rs1352305594
CA401495788
201 R>C No ClinGen
TOPMed
gnomAD
CA401495791
rs1213878850
201 R>H No ClinGen
TOPMed
gnomAD
CA401495808
rs1217101987
202 Y>C No ClinGen
TOPMed
CA401495888
rs1190563230
CA401495885
204 Q>H No ClinGen
gnomAD
CA401495876
rs1488610176
204 Q>R No ClinGen
gnomAD
CA401495929
rs1264921069
205 K>N No ClinGen
gnomAD
rs1434718027
CA401495951
206 I>T No ClinGen
gnomAD
rs1266577758
CA401495970
207 G>D No ClinGen
TOPMed
CA401495989
rs1419135924
208 D>G No ClinGen
gnomAD
rs1378474345
CA401495977
208 D>N No ClinGen
TOPMed
gnomAD
rs1401075459
CA401496038
209 D>E No ClinGen
TOPMed
gnomAD
CA8842088
rs754634656
209 D>N No ClinGen
ExAC
gnomAD
rs1293495447
CA401496052
210 L>F No ClinGen
gnomAD
CA401496187
rs1301503565
215 W>R No ClinGen
gnomAD
CA401496227
rs1375779374
216 L>F No ClinGen
gnomAD
rs1364149168
CA401496248
217 S>R No ClinGen
TOPMed
rs762346408
CA401497304
220 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA8842103
rs762346408
220 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1380723289
CA401497343
221 V>A No ClinGen
gnomAD
rs753414714
CA8842105
221 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA295100281
rs753414714
221 V>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 223 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA401497424
rs1228744881
224 C>Y No ClinGen
gnomAD
rs1315813878
CA401497449
225 R>C No ClinGen
TOPMed
gnomAD
rs371217388
CA401497460
225 R>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs373598736
CA8842108
228 A>T No ClinGen
ESP
ExAC
gnomAD
CA8842109
rs758161776
228 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1423606565
CA401497591
229 V>G No ClinGen
gnomAD
rs561479377
CA8842111
229 V>L No ClinGen
1000Genomes
ExAC
gnomAD
CA295100334
rs528738808
231 M>V No ClinGen
1000Genomes
gnomAD
rs1047414399
CA295100344
232 Q>R No ClinGen
Ensembl
rs550072079
CA295100370
233 Y>C No ClinGen
Ensembl
rs886976203
CA401497743
234 G>D No ClinGen
gnomAD
rs886976203
CA295100379
234 G>V No ClinGen
gnomAD
rs781413720
CA8842113
236 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA401497901
rs1297475505
239 Y>C No ClinGen
gnomAD
rs975953807
CA295100402
240 C>F No ClinGen
TOPMed
gnomAD
CA401497926
rs975953807
240 C>Y No ClinGen
TOPMed
gnomAD
CA295100417
rs867191607
241 W>R No ClinGen
Ensembl
rs1278539614
CA401497988
242 L>V No ClinGen
TOPMed
gnomAD
CA401498054
rs1276798780
244 V>A No ClinGen
gnomAD
CA8842116
rs775595105
249 L>V No ClinGen
ExAC
gnomAD
CA401498211
rs1458824170
250 H>Y No ClinGen
TOPMed
CA401498236
rs1242988043
251 N>I No ClinGen
TOPMed
gnomAD
rs749623311
CA8842117
251 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA401498234
rs1242988043
251 N>S No ClinGen
TOPMed
gnomAD
rs1271089900
CA401498277
254 G>A No ClinGen
TOPMed
CA401498267
rs1358089389
254 G>R No ClinGen
gnomAD
CA401498293
rs1318929566
255 L>P No ClinGen
gnomAD
CA401498319
rs1330246672
256 A>V No ClinGen
gnomAD
CA401498345
rs1373549347
258 L>F No ClinGen
TOPMed
gnomAD
CA401498368
rs1235094308
258 L>P No ClinGen
gnomAD
rs1351603095
CA401498391
259 P>L No ClinGen
gnomAD
CA401498399
rs999148337
260 E>* No ClinGen
TOPMed
gnomAD
CA295100479
rs999148337
260 E>K No ClinGen
TOPMed
gnomAD
CA401498395
rs999148337
260 E>Q No ClinGen
TOPMed
gnomAD
rs918016123
CA295100480
261 R>K No ClinGen
TOPMed
CA401498477
rs1197285173
262 S>I No ClinGen
gnomAD
CA8842122
rs776062273
262 S>R No ClinGen
ExAC
gnomAD
rs1568253337
CA401498459
262 S>R No ClinGen
Ensembl
rs1348115643
CA401498520
263 F>C No ClinGen
TOPMed
rs1454402740
CA401498595
266 L>I No ClinGen
gnomAD
rs758992810
CA8842123
267 Y>C No ClinGen
ExAC
gnomAD
rs1037221263
CA295100487
270 I>V No ClinGen
TOPMed
gnomAD
rs550972775
CA295100520
271 G>A No ClinGen
1000Genomes
gnomAD
rs995806123
CA295100515
271 G>S No ClinGen
TOPMed
gnomAD
CA295100652
rs772983197
274 A>G No ClinGen
Ensembl
rs772983197
CA401501049
274 A>V No ClinGen
Ensembl
rs1598238788
CA401501086
275 P>L No ClinGen
Ensembl
rs1439311133
CA401501198
279 V>I No ClinGen
gnomAD
CA8842131
rs548905669
280 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA401501288
rs1243202852
281 P>H No ClinGen
gnomAD
rs1295681226
CA401501317
282 W>* No ClinGen
gnomAD
rs1218451512
CA401501431
285 V>I No ClinGen
gnomAD
rs1366403753
CA401501535
287 C>G No ClinGen
TOPMed
CA8842132
rs781285550
287 C>Y No ClinGen
ExAC
TOPMed
gnomAD
CA401501645
rs1440223162
290 E>A No ClinGen
TOPMed
gnomAD
CA8842133
rs200674527
290 E>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA401501730
rs908475371
292 V>F No ClinGen
TOPMed
gnomAD
rs1168349939
CA401501742
292 V>G No ClinGen
gnomAD
CA295100731
rs908475371
292 V>I No ClinGen
TOPMed
gnomAD
CA401501998
rs1286468683
294 C>Y No ClinGen
TOPMed
rs575272671
CA295101031
297 S>N No ClinGen
1000Genomes
TOPMed
gnomAD
rs575272671
CA401502152
297 S>T No ClinGen
1000Genomes
TOPMed
gnomAD
rs761720188
CA8842151
299 D>N No ClinGen
ExAC
gnomAD
CA401502312
rs1262474272
301 M>I No ClinGen
gnomAD
CA401502310
rs1214298781
301 M>T No ClinGen
gnomAD
CA295101054
rs976661354
301 M>V No ClinGen
TOPMed
CA295101073
rs5387
VAR_033966
303 F>C No ClinGen
UniProt
TOPMed
dbSNP
rs5387
CA295101061
303 F>S No ClinGen
TOPMed
CA295101079
rs911455809
304 W>* No ClinGen
TOPMed
gnomAD
rs373391581
CA8842152
307 L>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1209087661
CA401502550
308 R>G No ClinGen
TOPMed
gnomAD
rs1266924744
CA401502575
308 R>L No ClinGen
gnomAD
rs1209087661
CA401502544
308 R>W No ClinGen
TOPMed
gnomAD
CA401502616
rs1195738034
310 P>L No ClinGen
TOPMed
gnomAD
COSM3362409
rs377519283
CA8842154
311 V>I kidney [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA401502729
rs1454621277
315 I>M No ClinGen
gnomAD
CA401502722
rs1198742291
315 I>N No ClinGen
TOPMed
rs774799702
CA8842165
319 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1223567514
CA401502940
319 F>Y No ClinGen
TOPMed
CA295101344
rs1049700509
320 F>S No ClinGen
TOPMed
gnomAD
rs762562348
CA8842166
322 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1256072758
CA401503023
322 F>L No ClinGen
gnomAD
TCGA novel 323 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8842167
rs151274323
323 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs371422062
CA295101353
324 R>C No ClinGen
ESP
TOPMed
gnomAD
CA401503091
rs1172127702
324 R>H No ClinGen
TOPMed
gnomAD
CA401503101
rs1453657226
325 I>V No ClinGen
TOPMed
gnomAD
CA401503130
rs1163082481
326 V>A No ClinGen
TOPMed
rs538739071
CA8842169
COSM1208018
326 V>I large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
rs1446709665
CA401503164
327 Q>* No ClinGen
gnomAD
rs997868355
CA295101358
327 Q>R No ClinGen
Ensembl
rs1310958309
CA401503192
328 L>P No ClinGen
gnomAD
CA401503187
rs1310958309
328 L>Q No ClinGen
gnomAD
CA295101369
rs371777245
330 V>M No ClinGen
TOPMed
gnomAD
rs1277265410
CA401503253
331 A>T No ClinGen
gnomAD
CA401503298
rs1417385628
332 K>N No ClinGen
TOPMed
rs1338189422
CA401503316
333 L>R No ClinGen
gnomAD
CA295101391
rs922855912
334 R>Q No ClinGen
TOPMed
gnomAD
rs976902380
CA295101378
334 R>W No ClinGen
TOPMed
gnomAD
CA295101392
rs954105221
335 A>T No ClinGen
TOPMed
gnomAD
VAR_085617
CA8842172
rs531523452
336 R>Q no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
UniProt
rs568466743
CA295101394
336 R>W No ClinGen
TOPMed
gnomAD
rs923638581
CA295101417
338 M>I No ClinGen
TOPMed
rs1486905557
CA401503510
339 H>R No ClinGen
gnomAD
rs867123159
CA295101422
340 H>Y No ClinGen
Ensembl
rs936322272
CA295101430
341 T>A No ClinGen
TOPMed
gnomAD
CA401503704
rs1419839154
346 R>Q No ClinGen
gnomAD
rs766354711
CA8842173
346 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA401503880
rs1211413966
348 A>G No ClinGen
gnomAD
CA295101663
rs867634648
348 A>T No ClinGen
Ensembl
CA401504037
rs1361576793
353 T>A No ClinGen
TOPMed
gnomAD
rs748764343
CA8842183
358 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1412736775
CA401504224
359 G>D No ClinGen
gnomAD
rs978118361
CA295101675
360 V>I No ClinGen
TOPMed
gnomAD
rs1441715310
CA401504310
362 E>K No ClinGen
TOPMed
gnomAD
CA401504314
rs1441715310
362 E>Q No ClinGen
TOPMed
gnomAD
rs370541643
CA8842185
366 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs947813160
CA295101699
369 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA401504637
rs1598240155
370 D>A No ClinGen
Ensembl
CA295101720
rs930645674
370 D>Y No ClinGen
Ensembl
CA401504660
rs1335016020
371 E>K No ClinGen
gnomAD
CA401504702
rs1197633258
372 H>N No ClinGen
TOPMed
gnomAD
CA401504698
rs1197633258
372 H>Y No ClinGen
TOPMed
gnomAD
rs1439063828
CA401504739
373 A>S No ClinGen
TOPMed
gnomAD
CA401504744
rs1439063828
373 A>T No ClinGen
TOPMed
gnomAD
rs1182403822
CA401504754
373 A>V No ClinGen
gnomAD
CA401504767
rs1272915623
374 Q>R No ClinGen
TOPMed
rs1313639238
CA401504771
375 G>S No ClinGen
TOPMed
gnomAD
CA8842190
rs372612289
376 T>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA401504807
rs372612289
376 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1474100584
CA401504831
378 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA401504835
rs1166903170
378 R>H No ClinGen
gnomAD
rs377211796
CA8842192
380 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1355452290
CA401505116
385 D>N No ClinGen
TOPMed
gnomAD
rs752844034
CA8842194
391 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1226174606
CA401505415
392 Q>* No ClinGen
gnomAD
rs376353664
CA295101868
393 G>S No ClinGen
ESP
rs1396277104
CA401506370
395 L>P No ClinGen
TOPMed
gnomAD
rs1287425806
CA401506961
396 V>E No ClinGen
gnomAD
rs747664695
CA8842204
398 V>I No ClinGen
ExAC
gnomAD
rs1458636561
CA401507060
399 L>P No ClinGen
TOPMed
gnomAD
TCGA novel 403 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA401507415
rs1253368710
407 V>M No ClinGen
gnomAD
CA401507454
rs1473117013
408 Q>* No ClinGen
gnomAD
rs1327302615
CA401507461
408 Q>P No ClinGen
TOPMed
rs527317042
CA401507494
409 S>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1187609450
CA401507487
409 S>P No ClinGen
gnomAD
rs527317042
CA8842218
409 S>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA401507549
rs1314672209
410 E>D No ClinGen
TOPMed
CA8842221
rs775647518
412 R>L No ClinGen
ExAC
TOPMed
gnomAD
COSM1589307
CA295102336
rs775647518
412 R>Q endometrium [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs552133484
CA8842220
412 R>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA295102358
rs887645895
413 R>Q No ClinGen
TOPMed
gnomAD
CA8842222
rs757894502
413 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs538504452
CA8842223
VAR_085619
414 R>H no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
UniProt
CA401507639
rs1374040087
414 R>S No ClinGen
gnomAD
CA295102382
rs1036169346
415 W>* No ClinGen
Ensembl
CA401507683
rs1258938272
415 W>* No ClinGen
TOPMed
rs878968533
CA295102373
415 W>R No ClinGen
Ensembl
CA8842225
rs137897678
416 H>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs137897678
VAR_085620
CA8842224
416 H>R no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
UniProt
CA401507706
rs1357168725
416 H>Y No ClinGen
gnomAD
rs1306988530
CA401507735
417 R>C No ClinGen
TOPMed
gnomAD
CA295102392
rs893269823
417 R>H No ClinGen
TOPMed
gnomAD
CA295102396
rs558491682
419 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA8842229
rs769673542
419 R>H No ClinGen
ExAC
gnomAD
rs769673542
CA8842228
419 R>L No ClinGen
ExAC
gnomAD
CA8842227
rs558491682
419 R>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 420 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1598241030
CA401507902
422 K>E No ClinGen
Ensembl
rs1030377149
CA295102403
422 K>R No ClinGen
Ensembl
CA401507960
rs1222479831
423 V>L No ClinGen
gnomAD
rs1487455874
CA401508005
424 L>P No ClinGen
TOPMed
gnomAD
CA401508049
rs1426204656
425 W>* No ClinGen
gnomAD
rs1171829126
CA401508154
428 R>G No ClinGen
TOPMed
gnomAD
rs61734385
CA8842231
VAR_085621
428 R>Q no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
UniProt
rs1171829126
CA401508168
428 R>W No ClinGen
TOPMed
gnomAD
rs1598241082
CA401508225
430 T>A No ClinGen
Ensembl
rs1311017995
CA401508234
430 T>I No ClinGen
gnomAD
CA401508335
rs1419560347
433 H>D No ClinGen
TOPMed
CA401508341
rs1377024369
433 H>P No ClinGen
gnomAD
rs1377024369
CA401508348
433 H>R No ClinGen
gnomAD
TCGA novel 437 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs545914836
CA8842232
VAR_085622
438 S>L no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
1000Genomes
ExAC
gnomAD
UniProt
rs183571856
CA8842234
440 G>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs183571856
CA8842233
440 G>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA401508647
rs1184549174
441 H>P No ClinGen
TOPMed
rs1021042497
CA295102441
442 G>S No ClinGen
gnomAD
CA295102443
rs188519815
442 G>V No ClinGen
1000Genomes
gnomAD
rs1211330325
CA401508737
443 P>S No ClinGen
gnomAD
rs1187930393
CA401508950
447 E>D No ClinGen
gnomAD
CA295102451
rs981152634
447 E>K No ClinGen
TOPMed
gnomAD
CA295102452
rs760905204
448 L>P No ClinGen
TOPMed
rs1390201837
CA401509057
449 Q>* No ClinGen
TOPMed
gnomAD
CA401509144
rs1232795692
451 G>A No ClinGen
TOPMed
rs1453320474
CA401509117
451 G>R No ClinGen
TOPMed
gnomAD
CA8842236
rs761153740
452 R>K No ClinGen
ExAC
rs1568255406
CA401509206
453 G>C No ClinGen
Ensembl
rs1396876164
CA401509327
455 G>R No ClinGen
TOPMed
gnomAD
CA401509348
rs1414985683
455 G>V No ClinGen
gnomAD
rs766891858
CA8842237
456 S>T No ClinGen
ExAC
TOPMed
gnomAD
CA295102470
rs936989263
457 Q>* No ClinGen
gnomAD
CA8842238
rs754349828
457 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA401509564
rs1365987180
458 D>E No ClinGen
gnomAD
RCV000966044
CA8842239
rs138492107
VAR_085623
458 D>H no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
UniProt
rs1444287207
CA401509570
459 S>P No ClinGen
TOPMed
CA8842240
rs13306383
VAR_085624
461 A>V no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
UniProt
CA401509798
rs1220319020
463 T>I No ClinGen
gnomAD
TCGA novel 465 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8842243
rs780849172
469 L>F No ClinGen
ExAC
gnomAD
rs975232367
CA295102536
473 A>V No ClinGen
TOPMed
gnomAD
CA401510242
rs1229366876
474 E>* No ClinGen
gnomAD
TCGA novel 474 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1283696557
CA401510283
475 S>R No ClinGen
gnomAD
rs745618150
VAR_085625
CA8842244
476 P>L no effect on glucagon-elicited cAMP production [UniProt] No ClinGen
ExAC
TOPMed
gnomAD
UniProt

1 associated diseases with P47871

[MIM: 619290]: Mahvash disease (MVAH)

An autosomal recessive disorder characterized by alpha-cell hyperplasia of the pancreas, hyperglucagonemia without glucagonoma syndrome, aminoacidemia, and occasional hypoglycemia. The disease may lead to glucagonomas and/or primitive neuroectodermal tumors. {ECO:0000269|PubMed:19657311, ECO:0000269|PubMed:23863937, ECO:0000269|PubMed:25695890, ECO:0000269|PubMed:30032256, ECO:0000269|PubMed:30294546, ECO:0000269|PubMed:32677665}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal recessive disorder characterized by alpha-cell hyperplasia of the pancreas, hyperglucagonemia without glucagonoma syndrome, aminoacidemia, and occasional hypoglycemia. The disease may lead to glucagonomas and/or primitive neuroectodermal tumors. {ECO:0000269|PubMed:19657311, ECO:0000269|PubMed:23863937, ECO:0000269|PubMed:25695890, ECO:0000269|PubMed:30032256, ECO:0000269|PubMed:30294546, ECO:0000269|PubMed:32677665}. Note=The disease is caused by variants affecting the gene represented in this entry.

4 regional properties for P47871

Type Name Position InterPro Accession
domain GPCR, family 2, extracellular hormone receptor domain 42 - 130 IPR001879
domain GPCR, family 2-like, transmembrane domain 141 - 404 IPR017981
conserved_site GPCR, family 2, secretin-like, conserved site 58 - 82 IPR017983-1
conserved_site GPCR, family 2, secretin-like, conserved site 392 - 407 IPR017983-2

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
  • Is rapidly internalized after ligand-binding
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
endosome A vacuole to which materials ingested by endocytosis are delivered.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

3 GO annotations of molecular function

Name Definition
G protein-coupled peptide receptor activity Combining with a peptide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
glucagon receptor activity Combining with glucagon and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
peptide hormone binding Binding to a peptide with hormonal activity in animals.

14 GO annotations of biological process

Name Definition
adenylate cyclase-activating G protein-coupled receptor signaling pathway A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity and a subsequent increase in the intracellular concentration of cyclic AMP (cAMP).
adenylate cyclase-modulating G protein-coupled receptor signaling pathway A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of adenylyl cyclase activity and a subsequent change in the intracellular concentration of cyclic AMP (cAMP).
cell surface receptor signaling pathway The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
cellular response to glucagon stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
cellular response to starvation Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
exocytosis A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle. Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule (for exemple of chromaffin cells) and the plasma membrane. The latter process most of the time leads to only partial secretion of the granule content. Exocytosis begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when molecules are secreted from the cell.
generation of precursor metabolites and energy The chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and any process involved in the liberation of energy from these substances.
glucose homeostasis Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
hormone-mediated signaling pathway The series of molecular signals mediated by the detection of a hormone.
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
regulation of blood pressure Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
regulation of glycogen metabolic process Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving glycogen.
response to nutrient Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
response to starvation Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P32241 VIPR1 Vasoactive intestinal polypeptide receptor 1 Homo sapiens (Human) PR
10 20 30 40 50 60
MPPCQPQRPL LLLLLLLACQ PQVPSAQVMD FLFEKWKLYG DQCHHNLSLL PPPTELVCNR
70 80 90 100 110 120
TFDKYSCWPD TPANTTANIS CPWYLPWHHK VQHRFVFKRC GPDGQWVRGP RGQPWRDASQ
130 140 150 160 170 180
CQMDGEEIEV QKEVAKMYSS FQVMYTVGYS LSLGALLLAL AILGGLSKLH CTRNAIHANL
190 200 210 220 230 240
FASFVLKASS VLVIDGLLRT RYSQKIGDDL SVSTWLSDGA VAGCRVAAVF MQYGIVANYC
250 260 270 280 290 300
WLLVEGLYLH NLLGLATLPE RSFFSLYLGI GWGAPMLFVV PWAVVKCLFE NVQCWTSNDN
310 320 330 340 350 360
MGFWWILRFP VFLAILINFF IFVRIVQLLV AKLRARQMHH TDYKFRLAKS TLTLIPLLGV
370 380 390 400 410 420
HEVVFAFVTD EHAQGTLRSA KLFFDLFLSS FQGLLVAVLY CFLNKEVQSE LRRRWHRWRL
430 440 450 460 470
GKVLWEERNT SNHRASSSPG HGPPSKELQF GRGGGSQDSS AETPLAGGLP RLAESPF